LLY · PEAD ↑ 100

Eli Lilly reported Q2 2026 EPS of $8.38 on 2026-08-05, beating the $6.01 consensus by $2.37 (+39.4%).

Print-day reaction was +4.9% versus the prior close, as shares gapped higher at the open and held gains through the session. The overnight move from T+0 close to T+1 open added another +2.3%, confirming institutional accumulation rather than a fade. The subsequent two-day drift extended the move a further +3.4%, with no meaningful give-back on either session. Cumulative abnormal return of +10.2% versus SPY.US places this decisively in PEAD long territory; the drift confirms and amplifies the initial reaction, with the holding window running through 2026-11-02.